Other languages NLS Pharmaceutics AG

Equities

NLSP

CH0523961370

Market Closed - Nasdaq Other stock markets 01:30:00 28/06/2024 am IST			5-day change	1st Jan Change
0.24 ^USD	+31.43%		+28.41%	-59.32%

27/06	Sector Update: Health Care Stocks Slipping Late Afternoon	MT
27/06	Sector Update: Health Care	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Slipping Late Afternoon	28/06
Sector Update: Health Care	28/06
Top Midday Gainers	27/06
European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk	27/06
NLS Pharmaceutics Reports Preclinical Data for Potential Parkinson's Disease Treatments; Shares Jump	27/06
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data	27/06
NLS Pharmaceutics AG Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists	12/06
NLS Pharmaceutics Says New Patent Application for Dual Non-Sulfonamide Orexin Receptor Agonists Published by WIPO	11/06
NLS Pharmaceutics AG Reports Earnings Results for the Full Year Ended December 31, 2023	16/05
Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors	09/04
NLS Pharmaceutics Files Plan to Regain Nasdaq Listing Compliance	23/02
NLS Pharmaceutics AG Reports Earnings Results for the Half Year Ended June 30, 2023	07/12
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	02/12
Sector Update: Health Care Stocks Rise in Afternoon Trading	02/12
Top Midday Gainers	02/12
NLS Pharmaceutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value	17/11
Top Premarket Gainers	31/23/31
Sector Update: Health Care Stocks Steady Pre-Bell Monday	03/23/03
NLS Pharmaceutics' Mazindol ER Trial to Move to Phase 3	03/23/03
NLS Pharmaceutics to Proceed with Phase 3 Clinical Program for Mazindol ER for the Treatment of Narcolepsy Following FDA Review and IRB Approval of the Full Study Protocol	03/23/03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NLS Pharmaceutics AG

Equities

NLSP

CH0523961370

Other languages

Filters